WASHINGTON — Pro-life groups are expressing deep concern after a document from the Food and Drug Administration (FDA) recently surfaced, showing that the government entity has contracted with a biomedical company to obtain “fetal tissue” to create mice with a human immune system in order to test drug safety and efficacy.
“The government intends to solicit and negotiate directly with Advanced Bioscience Resources (ABR) Inc. and no solicitation will be issued. The objective is to acquire tissue for humanized mice. ABR is the only company that can provide the human fetal tissue needed to continue the ongoing research being led by the FDA,” reads a pre-solicitation notice released in June.
“Fresh human tissues are required for implantation into severely immune-compromised mice to create chimeric animals that have a human immune system,” it explains. “This human immune system allows us to test biological drug products for safety and efficacy. This is necessary because these drug products do not bind non-human species drug targets.”
The FDA’s contract with ABR went into effect on July 25, according to information on the General Services Administration website, and will run for one year. The FDA is paying ABR $15,900 for the remains of unborn babies, referred to as “human fetal tissue,” for the research endeavor. ABR says that it obtains its “tissue” from first and second trimester abortions, as well as full-term deliveries.
“At the FDA, research involving human fetal tissue accounts for a very small fraction of the FDA’s total
The remainder of this article is available in its entirety at Christian News